Your browser doesn't support javascript.
loading
Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Keklik, Muzaffer; Deveci, Burak; Celik, Serhat; Deniz, Kemal; Gonen, Zeynep Burcin; Zararsiz, Gokmen; Saba, Rabin; Akyol, Gulsah; Ozkul, Yusuf; Kaynar, Leylagul; Keklik, Ertugrul; Unal, Ali; Cetin, Mustafa; Jones, Olcay Y.
Afiliación
  • Keklik M; Department of Hematology, Erciyes University, Kayseri, Turkey. muzafferkeklik@yahoo.com.
  • Deveci B; Hematology and Stem Cell Transplantation Unit, Medstar Antalya Hospital, Antalya, Turkey.
  • Celik S; Department of Hematology, Kirikkale University, Kirikkale, Turkey.
  • Deniz K; Department of Pathology, Erciyes University, Kayseri, Turkey.
  • Gonen ZB; Department of Oral and Maxillofacial Surgery, Faculty of Dentistry and Genome - Stem Cell Center, Erciyes University, Kayseri, Turkey.
  • Zararsiz G; Department of Biostatistics, Faculty of Medicine, Erciyes University and Turcosa Analytics Solutions Ltd. Co, Erciyes Teknopark, Kayseri, Turkey.
  • Saba R; Infectious Disease Unit, Medstar Antalya Hospital, Antalya, Turkey.
  • Akyol G; Department of Hematology, Erciyes University, Kayseri, Turkey.
  • Ozkul Y; Department of Medical Genetics, Medical School, Erciyes University, Kayseri, Turkey.
  • Kaynar L; Department of Hematology, Erciyes University, Kayseri, Turkey.
  • Keklik E; Department of Internal Medicine, Division of Hematology, Medipol University, Istanbul, Turkey.
  • Unal A; Department of Physiology, Kayseri City Hospital, Kayseri, Turkey.
  • Cetin M; Department of Hematology, Erciyes University, Kayseri, Turkey.
  • Jones OY; Hematology and Stem Cell Transplantation Unit, Medstar Antalya Hospital, Antalya, Turkey.
Ann Hematol ; 102(6): 1537-1547, 2023 Jun.
Article en En | MEDLINE | ID: mdl-37067556

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Trasplante de Células Madre Mesenquimatosas / Células Madre Mesenquimatosas / Enfermedad Injerto contra Huésped Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Trasplante de Células Madre Mesenquimatosas / Células Madre Mesenquimatosas / Enfermedad Injerto contra Huésped Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Alemania